Top Markets
#1 MowCat MowCat +48.87%
#2 Velvet Velvet +25.75%
#3 Quack AI Quack AI +21.37%
#4 Derive Derive +19.45%
#5 SkyAI SkyAI +17.12%
#6 Bermuda Shorts Bermuda Shorts +15.70%
#7 Geodnet Geodnet +15.17%
#8 aPriori aPriori +11.70%
#9 Cross Cross +11.69%
#10 Audiera Audiera +11.35%
Coin of the day
MowCat MowCat
Настройки
Язык
Pусский
Валюта
USD
Тема
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

QLGN
Ранг среди акций #35381
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing... Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.
Цена акции
$2.37
Последняя синхронизация: 2025-12-15
Рыночная капитализация
$3.99M
Изменение (1 день)
-5.58%
Изменение (1 год)
24.74%
Страна
US
Торговля Qualigen Therapeutics, Inc. (QLGN)

Категория

Healthcare
Коэффициент P/S для Qualigen Therapeutics, Inc. (QLGN)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Qualigen Therapeutics, Inc., текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для Qualigen Therapeutics, Inc. с 2026 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
Недостаточно данных для указанных дат.
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE